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It is crucial to assign the correct redox and ligand states to
crystal structures of proteins with an active redox centre to
gain valid functional information and prevent the misinter-
pretation of structures. Single-crystal spectroscopies, particu-
larly when applied in situ at macromolecular crystallography
beamlines, allow spectroscopic investigations of redox and
ligand states and the identification of reaction intermediates in
protein crystals during the collection of structural data. Single-
crystal resonance Raman spectroscopy was carried out in
combination with macromolecular crystallography on Swiss
Light Source beamline X10SA using cytochrome c0 from
Alcaligenes xylosoxidans. This allowed the fingerprinting and
validation of different redox and ligand states, identification of
vibrational modes and identification of intermediates together
with monitoring of radiation-induced changes. This combined
approach provides a powerful tool to obtain complementary
data and correctly assign the true oxidation and ligand state(s)
in redox-protein crystals.
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1. Introduction
It is essential that crystal structures of metalloproteins are
assigned to the correct redox and ligand states in order to gain
maximum functional information and to avoid, for example,
the misinterpretation of catalytic mechanisms. In the case of
haemproteins that bind small gaseous ligands, the ability to
identify the nature and occupancy of a ligand where there may
be limited differences in electron density is crucial. Recent
developments in single-crystal micro-spectrophotometry,
particularly when applied in situ on synchrotron macro-
molecular crystallography beamlines, allow systematic spec-
troscopic monitoring of redox and ligand states in the crystals
that are used for structure determination. This enables iden-
tification of the initial state of the crystal and its comparison
with solution data and also the ability to monitor changes
induced by X-ray irradiation.
The application of UV–visible spectroscopy to protein
single crystals has become well developed in recent years
(Pearson & Owen, 2009; Pearson et al., 2007; Owen et al., 2011;
Orville et al., 2011; Ellis et al., 2008; Antonyuk & Hough,
2011), while a number of beamlines, including those at the
ESRF, NSLS (Stoner-Ma et al., 2011) and Swiss Light Source
(SLS; Pompidor et al., 2013), also now have the capability
to conduct Raman spectroscopy either in non-resonance
(Carpentier et al., 2007; Katona et al., 2007; Bourgeois et al.,
2009) or resonance (RR; Daughtry et al., 2012) modes. The
preferred goal is to measure data from the X-ray-exposed
portion of the same crystal from which the crystal structure is
determined. Recent developments of the on-axis multi-mode
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Figure 1
(a) RR spectra measured from a ferric AxCYTcp crystal at 100 K. The redox marker 4 and the core size markers 3, 2 and 10 are clearly defined. (b)
X-ray-reduction kinetic series of 20 s RR measurements. The first spectrum is shown in blue, with reduction essentially complete after an absorbed X-ray
dose of 0.19 MGy. The inset shows the dose-dependent change in the bands at 1371 cm1 (red) and 1352 cm1 (blue). (c) RR spectra of ferric,
chemically reduced, laser-reduced and X-ray-reduced crystals. Several spectra for each state were measured before X-ray exposure to ensure that no
laser effects were apparent (except for the laser-reduced data) and only a single spectrum for each state is presented here. Data from a ferric crystal
(black) were measured over 30 s at 2 mW, data from an X-ray-reduced crystal (green) over 20 s at 0.88 mW and data from a chemically reduced
crystal (red) over 30 s at 2 mW. The laser-reduced spectrum shown (orange) was the final spectrum of a series of 20  30 s at 4.8 mW. Raman shifts
measured from all three ferrous crystals are consistent within experimental error with solution data for the ferrous form of AxCYTcp (Table 1).
microspectrophotometer (Pompidor et al., 2013) at beamline
X10SA of the SLS allow back-scattered resonance Raman
(RR) data to be conveniently measured along the same axis as
the X-ray beam (ensuring good alignment) with minimal or no
impact on the efficiency of crystallographic data collection.
The gas-binding haemprotein cytochrome c0 from the
denitrifying bacterium Alcaligenes xylosoxidans (AxCYTcp)
discriminates between nitric oxide (NO) and carbon
monoxide (CO) by binding them to opposite faces of haem
while excluding the binding of molecular oxygen. In the
absence of gaseous ligands, the haem Fe ion is five-coordinate
(5c) with a proximal histidine ligand and a vacant distal
coordination site. CO binds at the distal face to form a six-
coordinate (6c) adduct, while NO initially forms a 6c distal NO
adduct and proceeds via a transient dinitrosyl intermediate to
form the stable 5c proximal adduct, involving displacement of
the proximal histidine (Andrew et al., 2002; Lawson et al.,
2000). The 6c-to-5c conversion of NO ligation in cytochrome c0
has recently been confirmed to be highly relevant to the
mechanism of activation of soluble guanylate cyclase (Martin
et al., 2012; Tsai et al., 2011), and proximal NO binding also
occurs in the pro-apoptotic cytochrome c–cardiolipin complex
(Silkstone et al., 2012). In neither of these cases are structural
data available and AxCYTcp provides a valuable structural
model for NO binding.
Detailed solution RR studies have been performed on
AxCYTcp (Andrew et al., 2001, 2002, 2005; Kruglik et al.,
2007) and on a number of site-directed mutants (Antonyuk
et al., 2011; Hough et al., 2011; Garton et al., 2012). High-
resolution crystallographic analysis (Lawson et al., 2000;
Antonyuk et al., 2011; Hough et al., 2011) of this protein and
its mutants has provided detailed structural information, yet
correlating crystallographic and solution spectroscopic data
has remained a considerable challenge. The large irradiated
surface area and very high resolution diffraction of AxCYTcp
crystals, together with the wealth of comparative solution data,
make this protein an ideal test candidate for combined RR
and crystallographic methods.
In this study, we present a comprehensive, correlated single-
crystal RR and structural study of AxCYTcp in its ferric,
ferrous and gas ligand-bound forms as well as characterizing
X-ray-induced changes to these states. We demonstrate that
redox and ligand states in crystal structures can be effectively
spectroscopically fingerprinted in situ on the macromolecular
crystallography beamline X10SA. This approach, if applied
routinely to structural studies of haemproteins, has the
potential to radically increase and complement the biological
significance of the results gained from crystallographic
experiments, such as redox-dependent biological mechanisms.
2. Materials and methods
Recombinant native AxCYTcp was expressed and purified
and crystals were grown as described previously (Hough et al.,
2011; Antonyuk et al., 2011). Crystals were transferred into
a cryoprotectant solution consisting of 40% sucrose, 2.4M
ammonium sulfate, 100 mM HEPES buffer pH 7.5 for 10 s
before flash-cooling in liquid nitrogen. To generate the ferrous
state, ferric crystals were transferred into2 ml deoxygenated
mother-liquor solution containing 100 mM ascorbate within
a sealed glass bottle for 2 h. Ligand-bound states were
produced from ferrous crystals either via bubbling of CO gas
through the liquid for 5 min or injection of 10 ml of a stock
solution of the NO-donor compound ProliNONOate (Cayman
Chemical; Saavedra et al., 1996) in 25 mM NaOH into the
solution.
All crystallographic data were measured on SLS beamline
X10SA using a PILATUS 6M-F detector (Dectris; Henrich et
al., 2009). Data were processed using XDS (Kabsch, 2010) and
SCALA (Evans, 2006) in the CCP4 (Winn et al., 2011) suite.
The structures were refined using REFMAC5 (Murshudov et
al., 2011) using the most appropriate structures of AxCYTcp
from the Protein Data Bank as the starting models. Aniso-
tropic temperature factors were refined where the resolution
allowed, and riding H atoms were added to the models. Model
building between cycles of refinement was performed in Coot
(Emsley et al., 2010), and the quality of the structure was
monitored using MolProbity (Chen et al., 2010) and JCSG
Quality Control Check v.3.0. Measurements at elevated
cryogenic temperatures were obtained by varying the Cryojet
temperature setting. Data-collection and refinement statistics
are given in Supplementary Tables S1 and S2.1 Coordinates
and structure factors have been deposited in the RCSB
Protein Data Bank with the accession codes given in
Supplementary Table S1.
Single-crystal RR data were measured on beamline X10SA
from the same crystals immediately preceding or following
X-ray diffraction measurements. The on-axis multi-mode
microspectrophotometer versions MS2 (Pompidor et al., 2013)
and MS3 (Dworkowski et al., in preparation) were used with a
solid-state excitation laser (Omicron
Laserage LDM405, 400, CWA) wave-
length of 405.4 nm. The Andor Shamrock
303i spectrograph used a 2400 l mm1
grating, blazed at 300 nm. Spectra were
measured using an ANDOR Newton EM-
CCD DU-970N-UVB (1600  200 pixels;
Andor Technology PLC, Belfast,
Northern Ireland) cooled to 193 K in full
vertical binning mode. Raman shifts were
calibrated using cyclohexane or 4-
acetamidophenol as a reference. Laser
powers at the sample position were
measured using a PMD100D hand-held
power meter (Thorlabs Inc., New Jersey,
USA). All spectra were processed and background-subtracted
using the in-house SLS-APE analysis toolbox (Dworkowski et
al., manuscript in preparation). Absorbed X-ray doses were
calculated using the program RADDOSE-3D (Zeldin et al.,
2013).
3. Results
3.1. Measurement of resonance Raman data from AxCYTcp
crystals and monitoring of X-ray-reduction effects
Resonance Raman (RR) data over the wavenumber range
600–2000 cm1 were measured from native ferric AxCYTcp
crystals using 405.4 nm laser excitation and on-axis geometry2
(Fig. 1 and Supplementary Fig. S1). The spectra showed good
signal to noise, allowing a large number of Raman shifts to be
detected characteristic of haem porphyrin groups. The spec-
trum measured from a ferric AxCYTcp crystal was consistent
with equivalent solution data measured at 100 K (Table 1).
Raman shifts in the haem porphyrin marker region are shown
in Fig. 1(a) and Table 1. The values for the redox-state marker
4 and the haem core size markers 3 and 10 lie within 1 cm
1
of those measured in solution, while the remaining core size
marker 2 is shifted by 4 cm
1 in the crystal data. These small
differences are similar to the inherent resolution of the
instrumentation (3 cm1), but may also represent differ-
ences owing to the protein being in either a crystal lattice or in
the solution state. Raman spectra taken from several different
crystals of ferric AxCYTcp on separate visits to the beamline
gave values for the porphyrin marker bands that were
reproducible between 2–3 cm1 (data not shown). Laser
powers at the sample position3 were chosen below the
threshold at which laser-induced photoreduction of the
ferric haem is observed (<2.4 mW; Dworkowski et al., in
preparation4). Where appropriate, at least two consecutive
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Table 1
High-frequency Raman shifts (cm1) measured from crystals of AxCYTcp and comparative






 (nm) 4 3 2 10 Reference
Ferric solution 100 413.1 1370 1493 1581 1630 C. R. Andrew (unpublished data)
Ferric crystal 100 405.4 1369 1492 1577 1630 This work
Chemically reduced crystal 100 405.4 1350 1467 1582 1602 This work
X-ray-reduced crystal 100 405.4 1352 1466 n.o n.o This work
Laser-reduced crystal 100 405.4 1350 1467 1578 n.o This work
Ferrous solution 90 413.1 1353 1471 1579 1607 Andrew et al. (2002)
NO-bound solution 90 413.1 1375 1504 1596 1638 Andrew et al. (2002)
NO-bound crystal 100 405.4 1378 1512 1597 1648 This work
CO-bound solution 100 413.1 1370 — 1597 1634 Antonyuk et al. (2011)
CO-bound crystal 100 405.4 1369 — 1598 — This work
1 Supporting information has been deposited in the IUCr electronic archive
(Reference: TZ5051).
2 Note that the laser light (405.4 nm) penetrates only a few micrometres into
the crystal. An off-axis geometry without crystal reorientation would therefore
not fully sample the X-ray-irradiated area.
3 Laser powers given are those measured at the sample position unless
otherwise noted.
4 Note that for the laser spot size used, power densities are between
0.45 mW mm2 (for 0.88 mW power) and 2.45 mW mm2 (4.8 mW laser
power).
RR spectra in the absence of X-rays were taken for each
measurement in order to exclude laser-induced effects on the
crystals.
To investigate X-ray reduction of the ferric haem in
AxCYTcp crystals, a kinetic series of 50 RR spectra, each of
20 s laser exposure, were measured using a laser power of
0.88 mW. A ‘blank’ kinetic series measured first confirmed
that no laser-induced spectral changes were evident before the
X-ray shutter was opened. Upon X-ray irradiation, the spec-
trum of ferric haem was rapidly interconverted to a spectrum
with well resolved bands at 1352 and 1466 cm1 (Fig. 1b, Table
1) corresponding to the ferrous protein. Complete conversion
to the ferrous form was observed after a total absorbed X-ray
dose of 0.19 MGy (0.024 MGy per spectrum;5 Fig. 1b).
3.2. Measurement of a validated ferric haem crystal structure
Given that rapid X-ray-induced reduction of the AxCYTcp
haem iron(III) was observed, strategies were investigated to
measure an ‘intact’ spectrum of the ‘genuine’ ferric form, and
a multi-spot composite data-collection strategy was applied to
large crystals (>1 mm maximum dimension) of ferric
AxCYTcp. This approach is analogous to that used to deter-
mine an intact state of an X-ray-sensitive ferryl intermediate
in peroxidase (Meharenna et al., 2010). Five different positions
along the crystal were chosen and marked using the book-
marking feature of the data-collection GUI. Partial data sets,
each comprising 8 crystal rotation, were measured, with the
crystal translated to a new position between wedges. Rotation
ranges at adjacent positions had a 2 overlap in order to allow
accurate scaling.
A single RR spectrum was measured from the crystal prior
to X-ray exposure and at each bookmarked crystal position
following X-ray data collection to ensure that no observable
photoreduction had occurred (Supplementary Fig. S2). Each
RR spectrum was collected at the ! angle in the centre of the
rotation range used for the corresponding diffraction data
wedge. A total of 32 diffraction images were obtained at each
of the five positions at an X-ray wavelength of 0.8 A˚, an X-ray
flux of 2.97 1010 photons s1 and a beam size of 50 50 mm,
which were processed and merged together to give a complete
data set (Supplementary Table S1). With a highly attenuated
X-ray beam the absorbed dose per data set was only 7.9 kGy.
The resulting spectroscopically validated crystal structure for
the ferric protein was determined to 1.3 A˚ resolution. The
structure shows the Arg124 side chain in a position parallel to
the haem as previously proposed for the ferric state (Lawson
et al., 2000). Structural parameters for the haem site of this and
the other structures described herein are given in Table 2.
3.3. Comparison of crystals reduced chemically and by X-ray
irradiation
Combined X-ray and RR data were measured from crystals
reduced by different means: (i) chemical reduction using
sodium ascorbate prior to crystal cooling, (ii) in situ reduction
by exposure to X-rays and (iii) reduction by exposure to a
high-power (4.8 mW) excitation laser (600 s exposure) as
described in Dworkowski et al. (in preparation). All three
approaches yield similar spectra and indicate reduction of the
initial ferric haem in the crystal to the ferrous state (Fig. 1c),
with similar frequencies to those previously measured in
solution (Table 1). Crystal structures were determined from
chemically reduced crystals together with a crystal that had
been reduced by X-rays, with confirmatory RR data measured
to ensure that no further changes had occurred during crys-
tallographic data collection. Owing to the limited penetration
depth of the excitation laser of only a few micrometres (Adar
et al., 2010), a crystal with a depth greater than this penetra-
tion depth cannot be fully laser-reduced. To avoid possible
misinterpretation of a partially reduced state, we did not
measure diffraction data from a laser-reduced sample.
The porphyrin RR frequencies of chemically reduced and
X-ray-reduced crystals are similar (Table 1). Interestingly,
chemically and X-ray-reduced AxCYTcp structures show
large structural differences in the vicinity of the haem (Fig. 2),
including the orientation of Arg124, previously proposed as a
marker for sensing the Fe redox state. The ascorbate-reduced
structure (Fig. 2b) agrees with previously reported ferrous
AxCYTcp structures in which the Arg124 guanadinium group
is oriented perpendicular to the haem. By contrast, the X-ray-
reduced structure shows Arg124 parallel to the haem (Fig. 2c),
in a similar orientation to the ferric state (Fig. 2a). We propose
that the discrepancy between the chemically reduced and
X-ray-reduced structures is owing to the low (100 K)
temperature of the crystal, such that conformational re-
arrangements in the haem pocket following photoreduction
of haem Fe are restricted. To investigate this phenomenon
further, the X-ray reduction experiment was repeated using
fresh crystals at the elevated cryogenic temperatures of 160
and 180 K. These temperatures are lower than those at which
crystalline ice formation in the crystals occurs and thus good-
quality diffraction data could still be obtained. As expected,
the signal-to-noise of the RR data deteriorated rapidly as the
temperature was increased, but reduction could still be
monitored via the shift in the 4 band to 1350 cm
1, although
the other bands characteristic of the ferrous protein could not
be detected above the noise level.6
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Table 2











Ferric 1.30 2.05 — —
Chemically reduced 1.22 2.14 — —
X-ray-reduced (100 K) 1.17 2.12 — —
X-ray-reduced (160 K) 1.77 2.15 — —
X-ray-reduced (180 K) 1.55 2.04 — —
5c NO complex 1.26 — 1.84 42.1
5 The values quoted are the ‘threshold average dose’ calculated in
RADDOSE-3D (Zeldin et al., 2013).
6 Interestingly, however, the chemically reduced crystal showed a small
proportion (occupancy 0.2) of Arg124 in the ‘ferric’ orientation, suggesting
that reduction was not complete prior to freezing of the crystal.
The structure of AxCYTcp reduced by X-rays at 160 K was
determined to a resolution of 1.77 A˚, and in sharp contrast to
the data set measured at 100 K it displayed two conformations
of Arg124, with the minor one (occupancy 0.3) similar to that
present in the ferric structure and the major one (occupancy
0.7) corresponding to that in the chemically reduced
crystal (Fig. 2b), indicating that
conformational rearrangements
supressed at 100 K were able to
occur at higher temperatures.
Additional data measured at
180 K showed a similar structure,
again with a predominant
‘chemically reduced ferrous’
orientation of this side chain
(occupancy 0.7) evident with a
small component (occupancy 0.3)
of the ‘ferric’ orientation. A
superposition of the haem envir-
onments for the ferric, ascorbate-
reduced, X-ray-reduced (100 K),
X-ray-reduced (160 K) and
X-ray-reduced (180 K) structures
is shown in Fig. 2( f). The Fe–His
bond length was shortest (2.05 A˚)
in the composite ferric structure,
becoming slightly longer in crys-
tals reduced at 100 K (2.12 A˚) or
reduced using ascorbate (2.14 A˚).
In the structures determined at
160 and 180 K the values were
2.15 and 2.04 A˚, respectively,
which are essentially the same
given the lower resolution of
these higher temperature struc-
tures.
The structures determined at
160 and 180 K exhibited a higher
level of general radiation damage
(beyond the haem pocket) than
was the case at 100 K. While no
disulfide bonds are present in
AxCYTcp, decarboxylation and
loss of side-chain electron density
were very evident in the higher
temperature structures. The unit
cell underwent a small expansion
at higher temperature, with an
increase of 0.3 A˚ in a and b and
1.0 A˚ in c between 100 and
160 K, while no further change
was apparent between 160 and
180 K.
3.4. Monitoring of gas ligand-
bound states
Data were measured from
AxCYTcp crystals that had been
chemically reduced with sodium
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Figure 2
2Fo  Fc electron-density maps contoured at 1 showing the AxCYTcp crystal structures of (a) ferric, (b)
chemically reduced and (c) X-ray-reduced forms at 100 K. Additional X-ray-reduced structures determined
at different temperatures are shown at 160 K (d) and 180 K (e). ( f ) Superposition of X-ray-reduced
structures determined at 100 K (red), 160 K (grey) and 180 K (orange) with those of the chemically reduced
(green) and ferric (blue) crystals. Note that in the chemically reduced, 160 and 180 K structures a minor
occupancy conformation of Arg124 is present with density below the 1 level (see Supplementary Fig. S3).
ascorbate and exposed to either NO or CO prior to cooling to
100 K (Fig. 3). The CO-bound crystal exhibits porphyrin RR
characteristic of a 6c low-spin species: 4 (1369 cm
1) and 2
(1598 cm1), with 3 and 10 modes not observed owing to low
intensity. The RR spectrum for the NO-bound crystal is
characteristic of a 5c NO haem with porphyrin marker bands
4 (1378 cm
1), 3 (1512 cm
1), 2 (1597 cm
1) and 10
(1648 cm1) (Table 1). The 4 and 2 frequencies of the 6c CO
and 5c NO crystals at 100 K are similar to those of frozen
solutions (100 K), although the 3 and 10 frequencies of the 5c
NO complex are 8–10 cm1 higher in the crystalline state. This
mirrors the trend for the ferric and ferrous states (Table 1),
suggesting that the slight increases in the 3 and 10 frequen-
cies are a specific feature of the crystalline state. No laser-
induced dissociation of bound NO was observed in our
experiments and the crystal structure (Supplementary Fig. S4)
was essentially identical to that described previously (Hough
et al., 2011). Our data are consistent with previous work where
only X-ray dissociation of NO, not laser dissociation, was
observed in haemoglobin crystals (Merlino et al., 2013). In
contrast, the AxCYTcp–CO complex was found to be highly
susceptible to laser-induced ligand dissociation. At 5 mW laser
power at the sample, progressive conversion from the ferrous
CO spectrum to that of the ferrous 5c complex was observed
in successive spectra (Fig. 4). This is consistent with, for
example, flash-photolysis experiments, in which laser light at
similar wavelengths can be used to dissociate CO from haem
in order to investigate the kinetics of rebinding. We note here
that dissociation will only be observed in the penetration
depth of the laser into the crystal and thus this phenomenon, if
not monitored and avoided, could cause a discrepancy
between RR and crystallographic data measured on the same
crystal.
4. Discussion
The combined RR and crystallographic data described here
demonstrate that online RR spectroscopy is a powerful tool
for fingerprinting both redox and ligand states in single crys-
tals of haemproteins. RR spectroscopy allows information on
vibrational states to be gained and, if performed on-axis,
is particularly useful for large crystals, where UV–visible
absorption microspectrophotometry is not feasible owing to
the high optical density of the haemprotein crystals. High
signal-to-noise RR spectra over the wavenumber range 600–
2000 cm1 were obtained from AxCYTcp crystals at 100 K
using low laser powers (up to 1.95 mW) to avoid laser-induced
reduction of haem or ligand dissociation. Characteristic
spectra were measured for the ferric, ferrous, ferrous NO and
ferrous CO states with clear resolution of the redox-marker
band 4 and the core size marker bands 2, 3 and 10. The
corresponding structures were comparable to those previously
measured in crystallography-only experiments, but with an
increased level of functional state reliability as a result of
explicit validation of redox and ligand states.
RR data measured at 100 K from different redox and ligand
states generally matched the corresponding solution data
measured at the same temperature well. Some differences in
frequencies occurred and this may be owing to the changes to
vibrational modes imposed by the crystalline lattice. Never-
theless, ferric and ferrous states and 6c (CO) and 5c (NO)
complexes were clearly distinguished using RR data, allowing
these biologically relevant changes to be monitored and
followed by comparison to corresponding solution data. This
approach can identify mixed populations in crystals, for
example of ferric/ferrous oxidation state or incomplete ligand
binding, although only in the region penetrated by the laser.
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Figure 3
RR spectra measured from CO-bound (blue) and NO-bound (red)
AxCYTcp crystals. The sample laser power was 1.95 mW with 70 s
exposures. The spectra show characteristic frequencies for 6c (CO) and 5c
(NO) complexes, respectively, and a comparison with solution data is
given in Table 1.
Figure 4
Consecutive resonance Raman spectra from a CO-bound crystal, each
measured over 20 s of laser exposure at 5 mW power with no X-ray
exposure for a total irradiation time of 240 s. The starting (red) and final
(blue) spectra are highlighted. Significant laser effects consistent with
ligand dissociation were observed. Note that a degree of CO dissociation
occurred even during measurement of the starting spectrum, as indicated
by the shoulder in the 4 band at 1350 cm1 and the peak at
1465 cm1. The inset shows the decay of the Raman band at 1369 cm1
as a function of exposure time.
RR spectra measured from crystals of ferric AxCYTcp
before and after X-ray exposure showed significant changes
owing to the conversion of ferric to ferrous protein, with
reduction occurring following an X-ray dose of only 0.19 MGy.
X-ray photoreduction of haemprotein crystals has been well
characterized (see, for example, Beitlich et al., 2007). In the
case of AxCYTcp, significant structural differences in the
position of a proximal pocket arginine residue were observed
between structures determined from a crystal reduced by
X-rays and from a crystal chemically reduced using sodium
ascorbate prior to cooling, despite both having RR spectra
consistent with the ferrous state. This apparent discrepancy
was resolved by determination of the structures of X-ray-
reduced crystals at 160 and 180 K, which contained electron
density for both the ‘ferric’ and ‘ferrous’ arginine positions.
Given these results, it is possible that the ferric crystals used
for the determination of previous structures of AxCYTcp may
have undergone partial X-ray reduction of Fe, but that given
the lack of conformational changes observed between the
ferric and X-ray-reduced structures at 100 K this was not
apparent without complementary microspectrophotometric
data.
The temperature at which protein crystals undergo the
formation of crystalline ice and a catastrophic loss of crystal-
line order varies between crystals and is influenced by the size
of the solvent channels (Weik, Kryger et al., 2001). In acetyl-
cholinesterase (Weik, Kryger et al., 2001) this occurred at
>155 K, whereas in AxCYTcp it did not occur at either 160 or
180 K. The observation of partial occupancies of two distinct
Arg124 conformers in our 160 and 180 K AxCYTcp structures
argues that there are two distinct, energetically favourable
positions for the side chain and the flip from one to the other
requires a combination of sufficiently high thermal energy and
sufficiently low solvent viscosity. Weik, Kryger et al. (2001)
proposed that a solvent glass transition occurs between 100
and 155 K, with the higher temperature solvent displaying a
greatly decreased viscosity that facilitates conformational
changes in amino acids. Weik and coworkers have also
demonstrated that product escape (Colletier et al., 2008) and
side-chain flexibility (Weik, Ravelli et al., 2001) can be
observed in structures of acetylcholinesterase measured at
155 K that were supressed at 100 K.
Elevated temperatures above 150 K but below the
temperature at which crystals are damaged by crystalline ice
formation may facilitate the observation of relaxed or
responsive structures (Weik & Colletier, 2010). In the 160 and
180 K structures described here, in-crystal reduction by X-rays
has been achieved while still maintaining crystalline order and
diffracting power. The relatively lower temperature of 160–
180 K prevents the ‘destructive’ level of radiation damage
associated with room-temperature data collection, although
more radiation damage is observed than at 100 K.
High-quality characteristic vibrational frequencies of the
porphyrin marker bands were obtained for both NO-bound
and CO-bound states ofAxCYTcp, which were consistent with
the obtained crystal structures and solution data. However,
care must be taken when exposing CO-bound haemprotein
crystals to laser light, as this can lead to dissociation of the CO
ligand at high laser powers. Previous studies have shown that
in myoglobin, photo-dissociated CO was able to migrate away
from haem even at 20 K (Brunori et al., 2000).
Such effects are insidious as they will occur only in the part
of the crystal penetrated by the laser beam and may therefore
misrepresent the ligand status in the crystal as a whole. The
data described here using a 405 nm solid-state excitation laser
were limited to a lower wavenumber shift of600 cm1 owing
to the notch filters used within the instrument. A number of
important resonance Raman bands for Fe–CO and Fe–NO
complexes lie at lower wavenumbers (450 and 579 cm1;
Andrew et al., 2001), and future developments in the SLS
instrumentation will aim to access this important spectral
region.
In conclusion, high-resolution X-ray crystallography was
effectively combined with resonance Raman spectroscopy to
‘fingerprint’ and validate different redox and ligand states in
structures of AxCYTcp. This combination of techniques
provides a powerful tool to solve and correctly determine the
true redox and ligand states in haemprotein crystals and would
be valuable as a routine experimental procedure at advanced
crystallographic beamlines. The combination of online spec-
troscopic techniques with X-ray crystallography is particularly
important in micro-focused and nano-focused facilities, where
the X-ray photon density will be much higher than the original
facilities at the third-generation SR sources. The whole
armoury of spectroscopic probes, e.g. UV–Vis, RR and XAS,
have a significant role to play in providing functionally vali-
dated structures of redox proteins.
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at the University of Essex. We acknowledge the assistance
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and the JCSG for use of the Quality Control Check v.3.0 web
server.
References
Adar, F., Lee, E., Mamedov, S. & Whitley, A. (2010). Microsc.
Microanal. 16, 360–361.
Andrew, C. R., George, S. J., Lawson, D. M. & Eady, R. R. (2002).
Biochemistry, 41, 2353–2360.
Andrew, C. R., Green, E. L., Lawson, D. M. & Eady, R. R. (2001).
Biochemistry, 40, 4115–4122.
Andrew, C. R., Kemper, L. J., Busche, T. L., Tiwari, A. M., Kecskes,
M. C., Stafford, J. M., Croft, L. C., Lu, S., Moe¨nne-Loccoz, P.,
Huston, W., Moir, J. W. & Eady, R. R. (2005). Biochemistry, 44,
8664–8672.
Antonyuk, S. V. & Hough, M. A. (2011). Biochim. Biophys. Acta,
1814, 778–784.
Antonyuk, S. V., Rustage, N., Petersen, C. A., Arnst, J. L., Heyes, D. J.,
Sharma, R., Berry, N. G., Scrutton, N. S., Eady, R. R., Andrew, C. R.
& Hasnain, S. S. (2011). Proc. Natl Acad. Sci. USA, 108, 15780–
15785.
Beitlich, T., Ku¨hnel, K., Schulze-Briese, C., Shoeman, R. L. &
Schlichting, I. (2007). J. Synchrotron Rad. 14, 11–23.
Bourgeois, D., Katona, G., de Rosny, E. & Carpentier, P. (2009).
Methods Mol. Biol. 544, 253–267.
research papers
Acta Cryst. (2014). D70, 1289–1296 Kekilli et al.  Redox and ligand states in haemproteins 1295
Brunori, M., Vallone, B., Cutruzzola, F., Travaglini-Allocatelli, C.,
Berendzen, J., Chu, K., Sweet, R. M. & Schlichting, I. (2000). Proc.
Natl Acad. Sci. USA, 97, 2058–2063.
Carpentier, P., Royant, A., Ohana, J. & Bourgeois, D. (2007). J. Appl.
Cryst. 40, 1113–1122.
Chen, V. B., Arendall, W. B., Headd, J. J., Keedy, D. A., Immormino,
R. M., Kapral, G. J., Murray, L. W., Richardson, J. S. & Richardson,
D. C. (2010). Acta Cryst. D66, 12–21.
Colletier, J.-P., Bourgeois, D., Sanson, B., Fournier, D., Sussman, J. L.,
Silman, I. & Weik, M. (2008). Proc. Natl Acad. Sci. USA, 105,
11742–11747.
Daughtry, K. D., Xiao, Y., Stoner-Ma, D., Cho, E., Orville, A. M., Liu,
P. & Allen, K. N. (2012). J. Am. Chem. Soc. 134, 2823–2834.
Ellis, M. J., Buffey, S. G., Hough, M. A. & Hasnain, S. S. (2008). J.
Synchrotron Rad. 15, 433–439.
Emsley, P., Lohkamp, B., Scott, W. G. & Cowtan, K. (2010). Acta
Cryst. D66, 486–501.
Evans, P. (2006). Acta Cryst. D62, 72–82.
Garton, E. M., Pixton, D. A., Petersen, C. A., Eady, R. R., Hasnain,
S. S. & Andrew, C. R. (2012). J. Am. Chem. Soc. 134, 1461–
1463.
Henrich, B., Bergamaschi, A., Broennimann, C., Dinapoli, R.,
Eikenberry, E. F., Johnson, I., Kobas, M., Kraft, P., Mozzanica, A.
& Schmitt, B. (2009). Nucl. Instrum. Methods A, 607, 247–249.
Hough, M. A., Antonyuk, S. V., Barbieri, S., Rustage, N., McKay,
A. L., Servid, A. E., Eady, R. R., Andrew, C. R. & Hasnain, S. S.
(2011). J. Mol. Biol. 405, 395–409.
Kabsch, W. (2010). Acta Cryst. D66, 125–132.
Katona, G., Carpentier, P., Nivie`re, V., Amara, P., Adam, V., Ohana, J.,
Tsanov, N. & Bourgeois, D. (2007). Science, 316, 449–453.
Kruglik, S. G., Lambry, J. C., Cianetti, S., Martin, J. L., Eady, R. R.,
Andrew, C. R. & Negrerie, M. (2007). J. Biol. Chem. 282, 5053–
5062.
Lawson, D. M., Stevenson, C. E., Andrew, C. R. & Eady, R. R. (2000).
EMBO J. 19, 5661–5671.
Martin, E., Berka, V., Sharina, I. & Tsai, A. L. (2012). Biochemistry,
51, 2737–2746.
Meharenna, Y. T., Doukov, T., Li, H., Soltis, S. M. & Poulos, T. L.
(2010). Biochemistry, 49, 2984–2986.
Merlino, A., Fuchs, M. R., Pica, A., Balsamo, A., Dworkowski, F. S.
N., Pompidor, G., Mazzarella, L. & Vergara, A. (2013). Acta Cryst.
D69, 137–140.
Murshudov, G. N., Skuba´k, P., Lebedev, A. A., Pannu, N. S., Steiner,
R. A., Nicholls, R. A., Winn, M. D., Long, F. & Vagin, A. A. (2011).
Acta Cryst. D67, 355–367.
Orville, A. M., Buono, R., Cowan, M., He´roux, A., Shea-McCarthy,
G., Schneider, D. K., Skinner, J. M., Skinner, M. J., Stoner-Ma, D. &
Sweet, R. M. (2011). J. Synchrotron Rad. 18, 358–366.
Owen, R. L., Yorke, B. A., Gowdy, J. A. & Pearson, A. R. (2011). J.
Synchrotron Rad. 18, 367–373.
Pearson, A. R. & Owen, R. L. (2009). Biochem. Soc. Trans. 37,
378–381.
Pearson, A. R., Pahl, R., Kovaleva, E. G., Davidson, V. L. & Wilmot,
C. M. (2007). J. Synchrotron Rad. 14, 92–98.
Pompidor, G., Dworkowski, F. S. N., Thominet, V., Schulze-Briese, C.
& Fuchs, M. R. (2013). J. Synchrotron Rad. 20, 765–776.
Saavedra, J. E., Southan, G. J., Davies, K. M., Lundell, A., Markou, C.,
Hanson, S. R., Adrie, C., Hurford, W. E., Zapol, W. M. & Keefer,
L. K. (1996). J. Med. Chem. 39, 4361–4365.
Silkstone, G., Kapetanaki, S. M., Husu, I., Vos, M. H. & Wilson, M. T.
(2012). Biochemistry, 51, 6760–6766.
Stoner-Ma, D., Skinner, J. M., Schneider, D. K., Cowan, M., Sweet,
R. M. & Orville, A. M. (2011). J. Synchrotron Rad. 18, 37–40.
Tsai, A. L., Berka, V., Sharina, I. & Martin, E. (2011). J. Biol. Chem.
286, 43182–43192.
Weik, M. & Colletier, J.-P. (2010). Acta Cryst. D66, 437–446.
Weik, M., Kryger, G., Schreurs, A. M. M., Bouma, B., Silman, I.,
Sussman, J. L., Gros, P. & Kroon, J. (2001). Acta Cryst. D57,
566–573.
Weik, M., Ravelli, R. B. G., Silman, I., Sussman, J. L., Gros, P. &
Kroon, J. (2001). Protein Sci. 10, 1953–1961.
Winn, M. D. et al. (2011). Acta Cryst. D67, 235–242.
Zeldin, O. B., Gerstel, M. & Garman, E. F. (2013). J. Synchrotron Rad.
20, 49–57.
research papers
1296 Kekilli et al.  Redox and ligand states in haemproteins Acta Cryst. (2014). D70, 1289–1296
